会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 61. 发明授权
    • Strap for snowboard boots or bindings
    • US07669880B2
    • 2010-03-02
    • US11215727
    • 2005-08-29
    • Christopher DoyleRyan LarsonGregory DeanFlorian Lang
    • Christopher DoyleRyan LarsonGregory DeanFlorian Lang
    • A63C9/18
    • A43C11/146A63C10/06A63C10/24
    • A binding or boot strap is provided that allows a rider to easily, rapidly and/or effectively tighten and/or loosen the strap about his or her boot. The strap includes a boot-engaging strap portion that engages with an engagement strap coupleable to the boot, as may be the case with boots used for step-in bindings, or to the binding, as may be the case with strap-type bindings. An arrangement for facilitating tightening/loosening of the two strap pieces so that a rider can slip his or her foot into or out from the boot or fasten the boot to or loosen it from a snowboard binding is also provided. In one embodiment, this arrangement includes a tightening element, such as for example a cord, lace or strap, suitably coupled to one or both strap portions such that a rider can pull on the tightening element to move the strap pieces relative to each other and tighten the strap. The tightening arrangement may be configured with a mechanical advantage whereby the force applied to the tightening element results in a greater force applied to the strap. To take up any excess amount of tightening element after the strap has been tightened, a retraction device, such as a self-winding spool, may be utilized. To separate the strap from the boot or binding, a hook and catch arrangement may be employed.
    • 66. 发明申请
    • Use of a Novel Polymorphism in the Hsgk1 Gene in the Diagnosis of Hypertonia an Use of the Sgk Gene Family in the Diagnosis and Therapy of the Long Qt Syndrome
    • 在高血压诊断中使用Hsgk1基因中的新型多态性使用Sgk基因家族进行长Qt综合征的诊断和治疗
    • US20080015141A1
    • 2008-01-17
    • US10544576
    • 2004-02-05
    • Florian LangAndreas Busjahn
    • Florian LangAndreas Busjahn
    • A61K38/16A61K31/56C12Q1/68G01N33/00
    • A61K31/573A61K31/56A61K38/1841C12Q1/6883C12Q2600/156G01N33/573G01N33/6893G01N2333/9121
    • The invention relates to the use of a single-stranded or double-stranded nucleic acid comprising a fragment of hsgk for diagnosing hypertension, with said fragment being at least 10 nucleotides/base pairs in length and with said fragment furthermore comprising a polymorphism with ensues from the presence or absence of an insertion of the nucleotide G at position 732/733 in intron 2 of the hsgk1 gene. The invention furthermore relates to the use of the direct correlation between the overexpression or the functional molecular modification of human homologues of the sgk family and the length of the Q/T interval for diagnosing the long Q/T syndrome, and also to the use for the nucleic acid of a human homologue of the sgk gene family or of one of its fragments for diagnosing the long Q/T syndrome. In particular, polymorphisms of individual nucleotides (single nucleotide polymorphisms=SNP) in the human homologues of the sgk gene family can also, in the present case, be used for diagnosing a genetically determined predisposition for the long Q/T syndrome. In a further aspect, the invention relates to the use of a functional activator or transcription factor which increases the expression of the genes of the sgk family for producing a pharmaceutical for the therapy and/or prophylaxis of the long Q/T syndrome.
    • 本发明涉及包含hsgk片段的单链或双链核酸用于诊断高血压的用途,所述片段长度为至少10个核苷酸/碱基对,并且所述片段还包含多态性,随后来自 存在或不存在hsgk1基因的内含子2中位置732/733处的核苷酸G的插入。 本发明还涉及使用sgk家族的人类同源物的过表达或功能性分子修饰与用于诊断长Q / T综合征的Q / T间期的长度之间的直接相关性,以及用于 用于诊断长Q / T综合征的sgk基因家族的人类同源物的核酸或其片段之一的核酸。 特别地,在sgk基因家族的人类同源物中,单个核苷酸的多态性( single 核苷酸多态性= SNP) 在这种情况下,用于诊断长期Q / T综合征的遗传决定性倾向。 在另一方面,本发明涉及功能活化剂或转录因子的用途,其增加sgk家族的基因的表达以产生用于治疗和/或预防长Q / T综合征的药物。
    • 68. 发明申请
    • Clckb mutation as a diagnostic and therapeutical target
    • Clckb突变作为诊断和治疗靶点
    • US20050084485A1
    • 2005-04-21
    • US10687523
    • 2003-10-15
    • Florian LangSiegfried WaldeggerPhilipp LangAngelika LampertHannsjoerg SeybertNikola Jeck
    • Florian LangSiegfried WaldeggerPhilipp LangAngelika LampertHannsjoerg SeybertNikola Jeck
    • C12Q1/68A61K38/48C07H21/04C12N9/12
    • C12Q1/6883C12Q2600/156
    • The present invention relates to a method for diagnosing hypertension, and/or allergy, and/or hair loss, and/or liabilty for infection, of a human being, or a predisposition therefor; to a nucleic acid molecule coding for a human ClCKb protein comprising a genetic alteration at amino acid position 481 compared to the wild type, as well as for corresponding segments thereof; to a nucleic acid molecule which binds to the before-mentioned nucleic acid molecule under stringent conditions, as well as to a nucleic acid molecule which binds to that nucleic acid molecule; to a (poly)peptide encoded by the afore-mentioned nucleic acid molecules; to a method for identifying substances modulating activity of a peptide derived from ClCKb protein that is genetically altered at amino acid position 481 compared to the wild type; to a substance for modulating activity of a peptide derived from ClCKb protein that is genetically altered at amino acid position 481 compared to the wild type; to methods for preparing a pharmaceutical composition for treatment of hypertension, and/or allergy, and/or hair loss, and/or liability for infection; to pharmaceutical compositions; and to a method for treating a human being affected by hypertension, and/or allergy and/or hair loss, and/or liability for infection.
    • 本发明涉及一种用于诊断人类或其易感性的高血压,/或过敏和/或脱发,和/或感染的可能性的方法; 涉及编码人类ClCKb蛋白质的核酸分子,其包含与野生型相比在氨基酸位置481处的遗传改变,以及其对应的片段; 涉及在严格条件下与前述核酸分子结合的核酸分子,以及与该核酸分子结合的核酸分子; 涉及由上述核酸分子编码的(多)肽; 涉及一种用于鉴定与野生型相比在氨基酸位置481遗传改变的来自ClCKb蛋白的肽调节活性的物质的方法; 涉及调节与野生型相比在氨基酸位置481遗传改变的来自ClCKb蛋白的肽的活性的物质; 制备用于治疗高血压和/或过敏和/或脱发的药物组合物和/或感染责任的方法; 至药物组合物; 以及治疗受高血压,/或过敏和/或脱发影响的人的方法和/或感染责任。
    • 69. 发明授权
    • Cell volume-regulated human kinase h-sgk
    • 细胞体积调节人激酶h-sgk
    • US06326181B1
    • 2001-12-04
    • US09031295
    • 1998-02-26
    • Florian LangSiegfried Waldegger
    • Florian LangSiegfried Waldegger
    • C12N912
    • C12N9/1205A61K38/00
    • The present invention relates to the cloning and characterization of a human serine/threonine kinase (h-sgk: serum and glucocorticoid dependent kinase). The invention furthermore relates to reagents for diagnosing conditions associated with a change in cell volume and/or in “macromolecular crowding” in the body, such as, for example, hypernatremia, hyponatremia, diabetes mellitus, renal failure, hypercatabolism, hepatic encephalopathy, inflammation and microbial or viral infections. The present invention additionally relates to pharmaceuticals comprising the h-sgk, nucleic acids which code for the h-sgk, or receptors, in particular antibodies, which specifically bind to the h-sgk.
    • 本发明涉及人丝氨酸/苏氨酸激酶(h-sgk:血清和糖皮质激素依赖性激酶)的克隆和表征。 本发明还涉及用于诊断与细胞体积变化和/或体内“大分子拥挤”相关的病症的试剂,例如高钠血症,低钠血症,糖尿病,肾功能衰竭,高分泌症,肝性脑病,炎症 和微生物或病毒感染。 本发明还涉及包含h-sgk,编码h-sgk的核酸或特异性结合h-sgk的受体,特别是抗体的药物。